Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of ESPB on Intraoperative Remifentanil Consumption in Lumbar Spine Surgery

NCT06303557 is registered in ClinicalTrials.gov with Atatürk Chest Diseases and Chest Surgery Training and Research Hospital as lead sponsor.

NCT NCT06303557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06303557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of ESPB on Intraoperative Remifentanil Consumption in Lumbar Spine Surgery
Lead sponsor
Atatürk Chest Diseases and Chest Surgery Training and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2024
Completion date
November 13, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erector spinae plane block, lumbar spine surgery, remifentanil consumption